Delivery Order SPE2DB22D2211-SPE2DB24FMNV9
Award Date 1/10/24
Potential Completion Date 2/1/24
Potential Value $69K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 ml vials of the pharmaceutical OCREVUS. The $111,171.52 order is for delivery by January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contracts from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 ml vials of the pharmaceutical product OCREVUS. The $112,653.60 delivery order has a completion date of May 25, 2023 and was awarded on May 4, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals, medical supplies, and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of OCREVUS 300 mg/10 ml vial 10 ml. The contract has a potential value of $67,856.16 and a completion date of January 12, 2024. The award was made on December 20, 2023, and no set-aside designation was used. AmerisourceBergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products...
- This is a $23,118.08 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OCREVUS 300 mg/10 ml vials. The contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp, operating out of its corporate office in Conshohocken, Pennsylvania, has received numerous federal contracts from DLA to supply pharmaceuticals and medical supplies in support of military...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product OCREVUS 300 MG/10 ML VIAL 10ML. The order has a potential value of $23,118.08 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) the company...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The $124,402.96 contract is for supplies to be delivered by March 14, 2023. AmerisourceBergen Drug Corp, as the prime contractor, will fulfill this order from its corporate office located in Conshohocken, Pennsylvania. No set-aside designation was used...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 300 mg/10 mL vials of the pharmaceutical product Ocrevus. The $131,171.40 award has an August 18, 2022 completion date and was made on July 28, 2022. No set-aside designation was used. AmerisourceBergen Drug Corp, through its Corporate Office division, is an experienced government contractor that has received numerous DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide OCREVUS 300 MG/10 ML VIAL 10ML. The $23,118.08 contract has a June 3, 2024 ultimate completion date. This award is made under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 ml vials. The total potential value of the award is $128,918.52, with a completion date of October 15, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order, with a potential value of $131,171.40, is for 300 mg/10 ml vials of the drug OCREVUS. The order was placed against an existing contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support...